Brief: Biofrontera Q1 EBIT At EUR -3.97 Mln
11/05/2021 15:38
May 11 (Reuters) - BIOFRONTERA AG B8FGn.DE :
* SALES OF COMPANY FOR PERIOD FROM JANUARY 1 TO MARCH 31,
2021,
AMOUNTED TO EUR 5,479 THOUSAND, APPROXIMATELY 15% LOWER THAN
REVENUES OF EUR 6,473 THOUSAND IN SAME PERIOD LAST YEAR
* MAINTAINS ITS GUIDANCE FOR FISCAL YEAR 2021 PUBLISHED ON
APRIL
12, 2021
* Q1 EBIT AT EUR -3.97 MILLION
Source text for Eikon: ID:nPexM2sLca
Further company coverage: B8FGn.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Biofrontera AG
See all newsBrief: Biofrontera Says Co And Units Have Entered Into An Agreement With Biofrontera Inc About How To Settle Payment Obligations By Biofrontera Inc
Brief: Biofrontera AG Says Legal Dispute On Import In USA Will Result In Revised Outlook
Brief: Biofrontera AG Resolves Capital Increase From Authorized Capital
Brief: Biofrontera AG Says Plans Capital Reduction And Considers Subsequent Capital Increase From Authorized Capital
Brief: Biofrontera AG Says FY 2022 Total Revenue Amounted To EUR 25.7 Million